Clinical Trials Logo

Clinical Trial Summary

The investigators aimed to find appropriate biomarkers such as serum neurofilament light chain in reflecting disease severity in hereditary ataxia from a large cohort during long-term follow-up. The disease severity is indicated by clinical scales and brain MRI tests.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05160870
Study type Observational
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact Yi Dong
Phone + 8618367129345
Email dongyi720@zju.edu.cn
Status Recruiting
Phase
Start date June 30, 2021
Completion date December 25, 2025

See also
  Status Clinical Trial Phase
Completed NCT00004306 - Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10) N/A
Completed NCT04750850 - Core Stability Exercises and Hereditary Ataxia N/A
Active, not recruiting NCT06152133 - Telerehabilitation, Core Stability Exercises and Hereditary Ataxia (TRCore-ataxia) N/A
Recruiting NCT05160883 - Neuroimaging Changes in Hereditary Ataxia
Completed NCT00202397 - Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia Phase 2
Recruiting NCT01360164 - Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Hereditary Ataxia Phase 1/Phase 2